{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:9956119",
      "entity_text" : "CHIR99021",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P54829",
      "entity_text" : "step",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The second step is mesoderm induction with bone morphogenetic protein 4 (BMP4), activin A, and CHIR99021 for 2 days, followed by HE induction for 3 days with vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF2), SB431542, and stem cell factor (SCF).",
  "reading_complete" : "2020-08-05T18:46:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T18:40:41Z",
  "trigger" : "induction",
  "evidence" : [ "step is mesoderm induction with bone morphogenetic protein 4 (BMP4), activin A, and CHIR99021" ],
  "pmc_id" : "7154707",
  "score" : 0
}